Lowell, MA, United States of America

Stuart J Heminway

This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Squibb Pharma Company. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stuart J Heminway. Retrieved from https://idiyas.com/inventor/stuart-j-heminway

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Stuart J Heminway

Introduction

Stuart J Heminway is a notable inventor based in Lowell, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the imaging of angiogenic disorders. With a total of 2 patents to his name, Heminway's work has had a meaningful impact on medical imaging technologies.

Latest Patents

Heminway's latest patents focus on innovative pharmaceuticals designed for the imaging of angiogenic disorders. These advancements are crucial for improving diagnostic techniques and enhancing patient care in the medical field.

Career Highlights

Stuart J Heminway is currently employed at Bristol-Myers Squibb Pharma Company, where he continues to develop groundbreaking solutions in pharmaceuticals. His expertise and dedication to innovation have positioned him as a key figure in his industry.

Collaborations

Throughout his career, Heminway has collaborated with talented professionals, including Milind Rajopadhye and D Scott Edwards. These partnerships have fostered a creative environment that encourages the development of new ideas and technologies.

Conclusion

Stuart J Heminway's contributions to the field of pharmaceuticals and medical imaging exemplify the importance of innovation in healthcare. His work continues to inspire advancements that benefit both practitioners and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…